Tandem Diabetes Care (TNDM) Short Interest Ratio & Short Volume → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free TNDM Stock Alerts $44.72 +8.16 (+22.32%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Tandem Diabetes Care Short Interest DataCurrent Short Volume9,240,000 sharesPrevious Short Volume9,310,000 sharesChange Vs. Previous Month-0.75%Dollar Volume Sold Short$294.39 millionShort Interest Ratio / Days to Cover5.3Last Record DateApril 15, 2024Outstanding Shares64,560,000 sharesPercentage of Shares Shorted14.31%Today's Trading Volume5,986,916 sharesAverage Trading Volume1,279,958 sharesToday's Volume Vs. Average468% Short Selling Tandem Diabetes Care ? Sign up to receive the latest short interest report for Tandem Diabetes Care and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTNDM Short Interest Over TimeTNDM Days to Cover Over TimeTNDM Percentage of Float Shorted Over Time Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. Tandem Diabetes Care Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20249,240,000 shares $294.39 million -0.8%N/A5.3 $31.86 3/31/20249,310,000 shares $329.67 million +15.2%N/A5.1 $35.41 3/15/20248,080,000 shares $231.25 million +64.9%N/A4.5 $28.62 2/29/20244,900,000 shares $130.49 million -12.0%N/A2.7 $26.63 2/15/20245,570,000 shares $135.30 million +2.6%N/A3.5 $24.29 1/31/20245,430,000 shares $123.80 million +0.6%N/A3.6 $22.80 Get the Latest News and Ratings for TNDM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tandem Diabetes Care and its competitors with MarketBeat's FREE daily newsletter. 1/15/20245,400,000 shares $138.56 million -5.6%N/A3.1 $25.66 12/31/20235,720,000 shares $169.20 million -34.2%N/A3.3 $29.58 12/15/20238,690,000 shares $248.79 million +3.7%N/A5.1 $28.63 11/30/20238,380,000 shares $169.61 million +4.9%N/A5 $20.24 11/15/20237,990,000 shares $145.46 million -8.2%N/A4.9 $18.21 10/31/20238,700,000 shares $150.51 million -0.9%N/A5.6 $17.30 10/15/20238,780,000 shares $154.00 million +5.8%N/A6.2 $17.54 9/30/20238,300,000 shares $172.39 million +0.7%N/A5.6 $20.77 9/15/20238,240,000 shares $179.22 million +11.7%N/A5.8 $21.75 8/31/20237,380,000 shares $201.92 million -11.3%N/A5.3 $27.36 8/15/20238,320,000 shares $240.28 million +10.2%N/A6.1 $28.88 7/31/20237,550,000 shares $263.65 million +0.3%N/A5.3 $34.92 7/15/20237,530,000 shares $226.88 million +4.6%N/A5.5 $30.13 6/30/20237,200,000 shares $176.69 million +11.5%N/A5.8 $24.54 6/15/20236,460,000 shares $175.78 million +7.7%N/A5.5 $27.21 5/31/20236,000,000 shares $155.94 million -4.3%N/A4.5 $25.99 5/15/20236,270,000 shares $201.46 million +0.5%N/A4.6 $32.13 4/30/20236,240,000 shares $246.98 million -15.0%N/A4.8 $39.58 4/15/20237,340,000 shares $304.54 million -3.7%N/A6.2 $41.49 3/31/20237,620,000 shares $309.45 million +12.2%N/A6.2 $40.61 3/15/20236,790,000 shares $286.13 million +8.0%N/A5.6 $42.14 2/28/20236,290,000 shares $225.56 million +7.2%N/A6.2 $35.86 2/15/20235,870,000 shares $253.06 million +8.7%N/A5.9 $43.11 1/31/20235,400,000 shares $220.00 million +3.7%N/A5.4 $40.74 1/15/20235,210,000 shares $214.91 million -2.1%N/A4.5 $41.25 12/30/20225,320,000 shares $239.13 million +4.1%N/A4.6 $44.95 12/15/20225,110,000 shares $206.55 million -5.9%N/A4.4 $40.42 11/30/20225,430,000 shares $228.33 million -3.4%N/A4.1 $42.05 11/15/20225,620,000 shares $237.56 million -6.0%N/A4.4 $42.27 10/31/20225,980,000 shares $335.78 million +7.0%N/A4.6 $56.15 10/15/20225,590,000 shares $286.10 million +5.3%N/A4.9 $51.18 9/30/20225,310,000 shares $254.08 million +17.5%N/A4.7 $47.85 9/15/20224,520,000 shares $265.10 million +7.1%N/A4.2 $58.65 8/31/20224,220,000 shares $193.02 million +6.0%N/A4.2 $45.74Never use this word on your phone (FBI could be watching) (Ad)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...Watch my unredacted video about what I think is coming next right here TNDM Short Interest - Frequently Asked Questions What is Tandem Diabetes Care's current short interest? Short interest is the volume of Tandem Diabetes Care shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 9,240,000 shares of TNDM short. Learn More on Tandem Diabetes Care's current short interest. What is a good short interest ratio for Tandem Diabetes Care? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TNDM shares currently have a short interest ratio of 5.0. Learn More on Tandem Diabetes Care's short interest ratio. Which institutional investors are shorting Tandem Diabetes Care? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Tandem Diabetes Care: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Tandem Diabetes Care's short interest increasing or decreasing? Tandem Diabetes Care saw a decrease in short interest in April. As of April 15th, there was short interest totaling 9,240,000 shares, a decrease of 0.8% from the previous total of 9,310,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Tandem Diabetes Care's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Tandem Diabetes Care: ICU Medical, Inc. (5.71%), Integra LifeSciences Holdings Co. (3.95%), Inari Medical, Inc. (7.99%), PROCEPT BioRobotics Co. (11.04%), Alphatec Holdings, Inc. (8.65%), LeMaitre Vascular, Inc. (4.25%), Axonics, Inc. (7.92%), iRhythm Technologies, Inc. (9.03%), NovoCure Limited (6.27%), AtriCure, Inc. (6.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Tandem Diabetes Care stock? Short selling TNDM is an investing strategy that aims to generate trading profit from Tandem Diabetes Care as its price is falling. TNDM shares are trading up $8.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tandem Diabetes Care? A short squeeze for Tandem Diabetes Care occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TNDM, which in turn drives the price of the stock up even further. How often is Tandem Diabetes Care's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TNDM, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ICU Medical Short Interest Integra LifeSciences Short Interest Inari Medical Short Interest PROCEPT BioRobotics Short Interest Alphatec Short Interest LeMaitre Vascular Short Interest Axonics Short Interest iRhythm Technologies Short Interest NovoCure Short Interest AtriCure Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TNDM) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchWarren Buffet Stockpiling Gold?Reagan Gold Group